Search for: "PHS" Results 41 - 60 of 1,706
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Aug 2020, 7:03 am by Antonina Łęcka
Implicitly, the Court gave PH groups and similar organisations a green light to continue their operations. [read post]
31 Aug 2015, 6:49 pm
In 1981, PH drafted and typed a new will for MB which named PH as the sole beneficiary and executor of her estate. [read post]
26 May 2010, 4:00 pm by Heather Young
 PHS' hospitals provided more than $120 Million in charity care to the uninsured and indigent in 2009 and PHS' founder, Dr. [read post]
14 Jan 2011, 2:12 pm by By AZAM AHMED
The PH&N Absolute Return Fund has returned an average of more than 16 percent a year since it was started in 2002. [read post]
21 Jun 2016, 3:45 pm
Retired Patent Attorney, 30 years experience, accepting overflow work in electrical and mechanical fields. robertplattbell@gmail.com Ph. (703) 544-5281 [read post]
25 Mar 2008, 10:08 pm
(PHS) 2008-1205 "This report is the latest in... [read post]
21 Dec 2022, 4:00 pm by Laurent Teyssèdre
 Ce phénomène indésirable est observé dans le brevet par des tests spécifiques, utilisant par exemple le [read post]
7 Jun 2019, 4:59 pm by Jon Katz
Protecting the preliminary hearing (PH) right is critical, as underlined in my last blog entry. [read post]
12 Aug 2010, 2:03 pm
Public Health Service (PHS) personnel arising out of their official duties, precludes an action under Bivens v. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]